Johan Styrke

Kontakt

5A, Målpunkt H62, Norrlands universitetssjukhus Umeå universitet, 901 85 Umeå

Verksam vid

Anknuten som adjungerad universitetslektor till Institutionen för diagnostik och intervention

Adjungerad universitetslektor vid Institutionen för diagnostik och intervention

Clinical research nurses perceive their role as being like the hub of a wheel without real power: Empirical qualitative research

Nursing Open, John Wiley & Sons 2024, Vol. 11, (5)

Backman Lönn, Beatrice; Hörnsten, Åsa; Styrke, Johan; et al.

Population-based study of disease trajectory after radical treatment for high-risk prostate cancer

BJU International, John Wiley & Sons 2024, Vol. 134, (1) : 96-102

Stattin, Pär; Fleming, Sarah; Lin, Xiwu; et al.

Natural history of nonmetastatic prostate cancer managed with watchful waiting

JAMA Network Open, American Medical Association (AMA) 2024, Vol. 7, (6)

Ventimiglia, Eugenio; Gedeborg, Rolf; Styrke, Johan; et al.

Uptake of doublet therapy for de novo metastatic castration sensitive prostate cancer: a population-based drug utilisation study in Sweden

Scandinavian journal of urology, Medical Journals Sweden 2023, Vol. 58 : 93-100

Gedeborg, Rolf; Sandin, Fredrik; Thellenberg-Karlsson, Camilla; et al.

Use of antiepileptic drugs and risk of prostate cancer: a nationwide case-control study in prostate cancer data base Sweden

Journal of Oncology, Hindawi Publishing Corporation 2023, Vol. 2023

George, Gincy; Garmo, Hans; Adolfsson, Jan; et al.

Evidence of cancer progression as the cause of death in men with prostate cancer in Sweden

BJU International, John Wiley & Sons 2023, Vol. 131, (4) : 486-493

Orrason, Andri Wilberg; Styrke, Johan; Garmo, Hans; et al.

Frequency of biopsy and tumor grade before vs after introduction of prostate magnetic resonance imaging

JAMA Network Open, American Medical Association (AMA) 2023, Vol. 6, (8)

Robinson, David; Abdulkareem, Rafid; Nasrollah, Delshad; et al.

The risk of thromboembolism in patients with muscle invasive bladder cancer before and after cystectomy depending on blood group and neoadjuvant chemotherapy: a multicentre retrospective cohort study

Journal of Personalized Medicine, MDPI 2023, Vol. 13, (9)

Schulz Hägersten, Emma; Ottosson, Kristoffer; Pelander, Sofia; et al.

A prospective multicenter study of visual response-evaluation by cystoscopy in patients undergoing neoadjuvant chemotherapy for muscle invasive urinary bladder cancer

Scandinavian journal of urology, Taylor & Francis Group 2022, Vol. 56, (1) : 20-26

Asad, Danna; Styrke, Johan; Hagsheno, Mohammad; et al.

Clarifying the role of clinical research nurses working in Sweden, using the clinical trial nursing questionnaire: swedish version

Nursing Open, John Wiley & Sons 2022, Vol. 9, (5) : 2434-2443

Backman Lönn, Beatrice; Hajdarevic, Senada; Olofsson, Niclas; et al.

Transitioning to the clinical research nurse role: a qualitative descriptive study

Journal of Advanced Nursing, John Wiley & Sons 2022, Vol. 78, (11) : 3817-3829

Backman Lönn, Beatrice; Hörnsten, Åsa; Styrke, Johan; et al.

Time on treatment with abiraterone in men with de novo metastatic castration sensitive prostate cancer: a drug utilization study

Acta Oncologica, Taylor & Francis 2022, Vol. 61, (3) : 328-332

Gedeborg, Rolf; Garmo, Hans; Thellenberg-Karlsson, Camilla; et al.

Androgen deprivation therapy, comorbidity, cancer stage and mortality from COVID-19 in men with prostate cancer

Scandinavian journal of urology, Taylor & Francis 2022, Vol. 56, (2) : 104-111

Gedeborg, Rolf; Lindhagen, Lars; Loeb, Stacy; et al.

Susceptibility to SARS-Cov-2 infection and risk for severe COVID-19 in patients with prostate cancer on androgen deprivation therapy

International Journal of Cancer, John Wiley & Sons 2022, Vol. 151, (11) : 1925-1934

Gedeborg, Rolf; Loeb, Stacy; Styrke, Johan; et al.

Community-onset urosepsis: incidence and risk factors for 30-day mortality – a retrospective cohort study

Scandinavian journal of urology, Taylor & Francis 2022, Vol. 56, (5-6) : 414-420

Holmbom, Martin; Andersson, Maria; Grabe, Magnus; et al.

Nomograms including UBC^® Rapid Test to detect primary bladder cancer based on a multicenter data set

BJU International, John Wiley & Sons 2022, Vol. 130, (6) : 754-763

Meisl, Christina J.; Karakiewicz, Pierre I.; Einarsson, Roland; et al.

Diagnostic activity impacts lifetime risk of prostate cancer diagnosis more strongly than life expectancy

PLOS ONE, Public library of science 2022, Vol. 17, (11)

Orrason, Andri Wilberg; Westerberg, Marcus; Albertsen, Peter; et al.

A Phase 2 Trial of the Effect of Antiandrogen Therapy on COVID-19 Outcome: No Evidence of Benefit, Supported by Epidemiology and In Vitro Data

European Urology, Elsevier 2022, Vol. 81, (3) : 285-293

Welén, Karin; Rosendal, Ebba; Gisslén, Magnus; et al.

IMAGINE-IMpact Assessment of Guidelines Implementation and Education: The Next Frontier for Harmonising Urological Practice Across Europe by Improving Adherence to Guidelines

European Urology, Elsevier 2021, Vol. 79, (2) : 173-173

Cornford, Philip; Smith, Emma Jane; MacLennan, Steven; et al.

Timing of the pubertal growth spurt and prostate cancer

Cancers, MDPI 2021, Vol. 13, (24)

Célind, Jimmy; Bygdell, Maria; Martikainen, Jari; et al.

Rapid ascertainment of uptake of a new indication for abiraterone by use of three nationwide health care registries in Sweden.

Acta Oncologica, Taylor & Francis 2021, Vol. 60, (1) : 56-60

Fallara, Giuseppe; Lissbrant, Ingela Franck; Styrke, Johan; et al.

Prostate cancer diagnosis, staging, and treatment in Sweden during the first phase of the COVID-19 pandemic

Scandinavian journal of urology, Taylor & Francis 2021, Vol. 55, (3) : 184-191

Fallara, Giuseppe; Sandin, Fredrik; Styrke, Johan; et al.

Androgen deprivation therapy and excess mortality in men with prostate cancer during the initial phase of the COVID-19 pandemic

PLOS ONE, Public Library of Science 2021, Vol. 16, (10)

Gedeborg, Rolf; Styrke, Johan; Loeb, Stacy; et al.

Risk of cardiovascular events in men on abiraterone or enzalutamide combined with GnRH agonists: nation-wide, population-based cohort study in Sweden

Acta Oncologica, Taylor & Francis Group 2021, Vol. 60, (4) : 459-465

George, Gincy; Vikman, Hanna; Gedeborg, Rolf; et al.

Androgen Deprivation Therapy and the Risk for Inguinal Hernia: An Observational Nested Case Control Study

American Journal of Men's Health, Sage Publications 2021, Vol. 15, (6)

Hermann, Maria; Vikman, Hanna; Stattin, Pär; et al.

Patients' perspective on prostatic artery embolization: A qualitative study

SAGE Open Medicine, SAGE Open 2021, Vol. 9 : 1-6

Holm, Alexander; Lindgren, Hans; Blackberg, Mats; et al.

Short-term ciprofloxacin prophylaxis for prostate biopsy and risk of aortic aneurysm: nationwide, population-based cohort study

Scandinavian journal of urology, Taylor & Francis Group 2021, Vol. 55, (3) : 221-226

Lundström, Karl-Johan; Garmo, Hans; Gedeborg, Rolf; et al.

Control computerized tomography in neoadjuvant chemotherapy for muscle invasive urinary bladder cancer, has no value for treatment decisions and low correlation with nodal status

Scandinavian journal of urology, Taylor & Francis 2021, Vol. 55, (6) : 455-460

Tenninge, S.; Mogos, H.; Eriksson, E.; et al.

COVIDENZA - A prospective, multicenter, randomized PHASE II clinical trial of enzalutamide treatment to decrease the morbidity in patients with Corona virus disease 2019 (COVID-19): a structured summary of a study protocol for a randomised controlled trial

Trials, BioMed Central 2021, Vol. 22, (1)

Welén, Karin; Överby, Anna K.; Ahlm, Clas; et al.

Comparison of Relative Survival and Cause-Specific Survival in Men With Prostate Cancer According to Age and Risk Category: A Nationwide, Population-Based Study

American Journal of Epidemiology, Oxford University Press 2021, Vol. 190, (10) : 2053-2063

Wilberg Orrason, Andri; Garmo, Hans; Styrke, Johan; et al.

Observational study on time on treatment with abiraterone and enzalutamide

PLOS ONE, Public Library of Science 2020, Vol. 15, (12)

Fallara, Giuseppe; Lissbrant, Ingela Franck; Styrke, Johan; et al.

Computerized tomography before the final treatment cycle of neoadjuvant chemotherapy or induction chemotherapy in muscle-invasive urinary bladder cancer, cannot predict pathoanatomical outcomes and does not reflect prognosis-results of a single centre retrospective prognostic study

Translational Andrology and Urology, AME Publishing Company 2020, Vol. 9, (3) : 1062-1072

Mogos, Haben; Eriksson, Elisabeth K; Styrke, Johan; et al.

Use of Warfarin or Direct Oral Anticoagulants and Risk of Prostate Cancer in PCBaSe: A Nationwide Case-Control Study

Frontiers in Oncology, Frontiers Media S.A. 2020, Vol. 10

Parker, Jonathan; Crawley, Danielle; Garmo, Hans; et al.

Current routines for antibiotic prophylaxis prior to transrectal prostate biopsy: a national survey to all urology clinics in Sweden

F1000 Research, F1000 Research Ltd 2020, Vol. 9

Styrke, Johan; Resare, Sven; Lundström, Karl-Johan; et al.

Mini Review on the Use of Clinical Cancer Registers for Prostate Cancer: The National Prostate Cancer Register (NPCR) of Sweden

Frontiers in Medicine, Frontiers Media S.A. 2019, Vol. 6

Cazzaniga, Walter; Ventimiglia, Eugenio; Alfano, Massimo; et al.

Occurrence of abdominal bulging and hernia after open partial nephrectomy: a retrospective cohort study

Scandinavian journal of urology, Taylor & Francis 2018, Vol. 52, (1) : 54-58

Inkiläinen, Aapo; Styrke, Johan; Ljungberg, Börje; et al.

Evaluation of the diagnostic accuracy of UBC(®) Rapid in bladder cancer: a Swedish multicentre study

Scandinavian journal of urology, Vol. 51, (4) : 293-300

Styrke, Johan; Henriksson, Helene; Ljungberg, Börje; et al.

Symptoms, disability, and life satisfaction five years after whiplash injuries

Scandinavian Journal of Pain, Elsevier 2014 : 229-236

Styrke, Johan; Sojka, Peter; Björnstig, Ulf; et al.

Neck injury after whiplash trauma in a defined population in Northern Sweden: long term sick leave and costs of low productivity

Epidemiology: Open Access, Vol. 4, (4)

Styrke, Johan; Stålnacke, Britt-Marie; Bylund, Per-Olof; et al.

Sex-differences in symptoms, disability, and life satisfaction three years after mild traumatic brain injury: a population-based cohort study

Journal of Rehabilitation Medicine, Stiftelsen Rehabiliteringsinformation 2013, Vol. 45, (8) : 749-757

Styrke, Johan; Sojka, Peter; Björnstig, Ulf; et al.

Long-term follow-up of patients with mild traumatic brain injury: a mixed-methods study

Journal of Rehabilitation Medicine, Stiftelsen Rehabiliteringsinformation 2013, Vol. 45, (8) : 758-764

Åhman, Sara; Saveman, Britt-Inger; Styrke, Johan; et al.

Traumatic brain injuries and whiplash injuries: epidemiology and long-term consequences

Umeå University medical dissertations, 1526

Styrke, Johan

A 10-year incidence of acute whiplash injuries after road traffic crashes in a defined population in Northern Sweden

PM&R, New York, NY, USA: Elsevier 2012, Vol. 4, (10) : 739-747

Styrke, Johan; Stålnacke, Britt-Marie; Bylund, Per-Olof; et al.

Traumatic brain injuries in a well-defined population: epidemiological aspects and severity

Journal of Neurotrauma, New York, NY, USA: Mary Ann Liebert, Inc. 2007, Vol. 24, (9) : 1425-1436

Styrke, Johan; Stålnacke, Britt-Marie; Sojka, Peter; et al.

Clinical research nurses percieve their role as being like the hub in the wheel without real power: Empirical qualitative research

Backman Lönn, Beatrice; Hörnsten, Åsa; Styrke, Johan; et al.

Whiplash trauma: epidemiology, long-term sick leave and its' costs

Styrke, Johan; Stålnacke, Britt-Marie; Bylund, Per-Olof; et al.

Visa publikationer i DiVA

Forskningsprojekt

1 januari 2018

Testiscancer

1 januari 2018

Urinblåsecancer